Document is current

Article History

Received: 13 April 2023

Accepted: 2 January 2024

First Online: 28 February 2024

Declarations

:

: The study was approved by the Institutional Review Board/Institutional Ethics Committee of each study site, and the study was performed according to consensus ethics principles derived from international ethics guidelines, including the Declaration of Helsinki and the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines for Good Clinical Practice (GCP), all applicable laws, rules, and regulations. A signed written informed consent form was obtained from each patient before conducting any study-related procedures.

: Not applicable.

: Clot PF, Farenc C, Krahnke T, Staudinger H, Suratt BT, Pomponio R, Tardat A, Patel N, Wiekowski M, Lin Y: Sanofi employees, may hold stock and/or stock options in the company. Florian P: Sanofi employee when this work was conducted and holds Sanofi stock; now works for Boehringer Ingelheim Vetmedica GmbH. Terrier B: Received consulting fees from Roche, Chugai, GSK, AstraZeneca, BMS, Terumo BCT, Sanofi, LFB, Grifols.

: European Respiratory Society – 31st Annual Congress (ERS 2021).